Background. Increased mortality from lymphoid malignancies following exposure to environmental selenium has recently been reported, Moreover, conflicting results have been found in investigations examining the relationship between serum concentrations of selenium and some clinical features of malignant lymphoproliferative diseases. Methods, Serum concentrations of selenium were analyzed by atomic absorption spectrometry in fifty-nine patients with newly diagnosed chronic lymphoid malignancies and in forty control subjects. Results. Selenium concentrations were significantly lower in patients than in control subjects, However, when only patients with localized disease were compared to controls, no significant difference in serum selenium concentrations was observed. Clinical stage was inversely associated with selenium levels. High-grade non-Hodgkin's lymphoma was characterized by lower selenium levels than low-grade and intermediate-grade disease. Selenium levels were positively associated with albumin and hemoglobin, and inversely correlated with serum concentrations of beta 2-microglobulin and with erythrocyte sedimentation rate. Conclusions. The findings of this study do not suggest that a high selenium intake represents a risk factor for malignant lymphoproliferative diseases, but limitations of the investigation hamper evaluation of the results. The possible utility of determining serum concentrations of selenium in the clinical evaluation ofpatients with lymphoid malignancies merits examination in larger studies.

Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies / P., Avanzini; Vinceti, Marco; F., Ilariucci; L., Masini; M., Dinca; Vivoli, Gianfranco. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 80:(1995), pp. 505-511.

Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies

VINCETI, Marco;VIVOLI, Gianfranco
1995-01-01

Abstract

Background. Increased mortality from lymphoid malignancies following exposure to environmental selenium has recently been reported, Moreover, conflicting results have been found in investigations examining the relationship between serum concentrations of selenium and some clinical features of malignant lymphoproliferative diseases. Methods, Serum concentrations of selenium were analyzed by atomic absorption spectrometry in fifty-nine patients with newly diagnosed chronic lymphoid malignancies and in forty control subjects. Results. Selenium concentrations were significantly lower in patients than in control subjects, However, when only patients with localized disease were compared to controls, no significant difference in serum selenium concentrations was observed. Clinical stage was inversely associated with selenium levels. High-grade non-Hodgkin's lymphoma was characterized by lower selenium levels than low-grade and intermediate-grade disease. Selenium levels were positively associated with albumin and hemoglobin, and inversely correlated with serum concentrations of beta 2-microglobulin and with erythrocyte sedimentation rate. Conclusions. The findings of this study do not suggest that a high selenium intake represents a risk factor for malignant lymphoproliferative diseases, but limitations of the investigation hamper evaluation of the results. The possible utility of determining serum concentrations of selenium in the clinical evaluation ofpatients with lymphoid malignancies merits examination in larger studies.
80
505
511
Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies / P., Avanzini; Vinceti, Marco; F., Ilariucci; L., Masini; M., Dinca; Vivoli, Gianfranco. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 80:(1995), pp. 505-511.
P., Avanzini; Vinceti, Marco; F., Ilariucci; L., Masini; M., Dinca; Vivoli, Gianfranco
File in questo prodotto:
File Dimensione Formato  
505.full.pdf

Open access

Tipologia: Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione 141.7 kB
Formato Adobe PDF
141.7 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/309684
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 10
social impact